Prosecution Insights
Last updated: April 19, 2026
Application No. 18/037,566

ECG Monitoring Device Combined with BCG Signal

Final Rejection §102
Filed
May 18, 2023
Examiner
JOHNSON, NICOLE F
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Shenzhen Glamour Technology Co. Ltd.
OA Round
2 (Final)
87%
Grant Probability
Favorable
3-4
OA Rounds
2y 11m
To Grant
95%
With Interview

Examiner Intelligence

Grants 87% — above average
87%
Career Allow Rate
1180 granted / 1350 resolved
+17.4% vs TC avg
Moderate +7% lift
Without
With
+7.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
54 currently pending
Career history
1404
Total Applications
across all art units

Statute-Specific Performance

§101
8.9%
-31.1% vs TC avg
§103
34.3%
-5.7% vs TC avg
§102
33.7%
-6.3% vs TC avg
§112
9.7%
-30.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1350 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 2-3 & 7-10 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected specie(s), there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on August 18, 2025. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Lu et al. (WO 2018/231444). 1. A dual-signal collection electrode sticker, wherein the dual- signal collection electrode sticker comprises an electrode cable interface, a BCG sensing layer and an ECG electrode layer, E.G. via the disclosed SCG sensor 110 and the ECG electrode(s) 102 integrated together on a single, wearable patch 100 [0037], further comprising ribbons 102, 104 directly associated with said sensor 110 and ECG electrodes {[0044] & (Fig 1)}. Note that the examiner is interpreting the disclosed ribbons 102, 104 as being the claimed electrode cable interface. the electrode cable interface is located at the center of the dual-signal collection electrode sticker, the BCG sensing layer is located above the ECG electrode layer; the dual-signal collection electrode sticker is in a flat cake-shaped structure as a whole; E.G. via the disclosed tattoo-patch 100 which houses the ribbons 102, 104 incorporated on said patch, wherein the sensor is fabricated and patterned onto a substrate in relation to the ECG electrodes {[0044], [0047] & (Figs 1& 2)}. wherein the electrode cable interface comprises two BCG cable wires and an ECG cable wire, the BCG sensing layer comprises two layers of BCG sensing electrodes and a layer of BCG piezoelectric sensing material positioned between the two layers of BCG sensing electrodes, E.G. via the disclosed serpentine ribbons that are incorporated unto the patch and the fabrication process that details the creation/patterning of piezo film sheets in respect to the ECG electrodes and SCG sensor {[0016], [0047]-[0049] & (Fig 1)}. the ECG electrode layer comprises one layer of ECG sensing electrode and a conductive gel located at the bottom; the two BCG cable wires being respectively connected with the two layers of BCG sensing electrodes, the ECG cable wire is connected with the one layer of ECG sensing electrode; E.G. {[0047]-[0049] & (Fig 1)}. the BCG sensing layer converts vibration signals into electrical signals, the ECG electrode layer collects the ECG signal in the manner of ECG lead. E.G. ([0011]-[0012] & [0022]-[0023]). Response to Arguments Applicant’s arguments, filed December 29, 2025, with respect to the 35 U.S.C. §101 and §112(b) claim rejections have been fully considered and are persuasive and have been withdrawn, per the applicant’s amendments made to the claims. Applicant’s arguments with respect to claim(s) 1 & 4-6 in respect to the 35 U.S.C. §103 rejection have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Please see the above action. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICOLE F JOHNSON whose telephone number is (571)270-5040. The examiner can normally be reached Monday-Friday 8:00am-5:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, David Hamaoui can be reached at 571-270-5625. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICOLE F JOHNSON/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 18, 2023
Application Filed
Sep 06, 2025
Non-Final Rejection — §102
Dec 29, 2025
Response Filed
Mar 09, 2026
Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599328
METHOD TO DETECT NOISE IN A WEARABLE CARDIOVERTER DEFIBRILLATOR
2y 5m to grant Granted Apr 14, 2026
Patent 12594420
TETHER ASSEMBLIES FOR MEDICAL DEVICE DELIVERY SYSTEMS
2y 5m to grant Granted Apr 07, 2026
Patent 12588858
WEIGHTING PROJECTED ELECTROPHYSIOLOGICAL WAVE VELOCITY WITH SIGMOID CURVE
2y 5m to grant Granted Mar 31, 2026
Patent 12575803
THERAPEUTIC DEVICE INCLUDING ACOUSTIC SENSOR
2y 5m to grant Granted Mar 17, 2026
Patent 12569162
BREATH ANALYSIS SYSTEM WITH PREDICTIVE SENSOR PREPARATION
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
87%
Grant Probability
95%
With Interview (+7.2%)
2y 11m
Median Time to Grant
Moderate
PTA Risk
Based on 1350 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month